Introduction
Ursodeoxycholic acid (UDCA) is an active pharmaceutical ingredient (API) used in clinicalt herapy for the treatmento fc holestatic diseases. [1] It is as econdary bile acid that, as reported in severalp apers and reviews, shows several pharmacological effects. [2, 3] Particularly,U DCA dissolves cholesterol gallstones, acting as as urfactant. [4, 5] In addition, other functions and influences on human physiology have been discovered;f or example, UDCA improves the liver functioni nc holestatic diseases through secretion of glutathione [6, 7] and interaction with several receptors, [8, 9] and significantly decreases cholesterol saturation in the bile. [10, 11] Recently,o ther studies demonstrated antitumorigenice ffects and al ower risk for some cancers. [12] In comparison to chenodeoxycholic acid (CDCA), which is also used in therapies, UDCA provides total absence of side effects maintaining ah igh efficacy,i nt erms of pharmacological effects. [13, 14] This API has been known in Chineset raditional medicine for many years, but naturalU DCA can only be obtained by isolation from bear bile, making it very expensive. [15] The current viable route for this API consists of chemical transformation of cholic acid (CA) or CDCA. These bile acids are obtained from the cheaper and more available bovineb ile that represents, in terms of industrial feasibility,t he only source of hydroxysteroids. Currently,C Ai sc hemically transformed into UDCA by as even-step chemical synthesis. [16, 17] Unfortunately this route, first proposed by Hofmann, [16] requires the employment of toxic and dangerousr eagents (e.g.,h ydrazine, Cr 2 O, and pyridine) and results in large amounts of waste. In addition, it only has an overall yield of about 30 %. To improve the efficiency of UDCA synthesis, alternative chemical routes have been proposed.D angate et al., [18] for example, achieved the transformation of CA into UDCA (53 %y ield using o-iodobenzoic acid, hydrazine,a nd metallics odium in n-propanol) without the protection and deprotection steps used in the original route.H owever,t his process is stilln ot optimized in terms of costs and environmental impact. UDCA can also be obtained by epimerization of CDCA (intermediate in the synthesis of CA). In the latter case, av iable production route would need to be complemented by an ovel synthetic route for CDCA, because of the low natural availability of this compound. [19] An emerging technology for the modification of hydroxysteroids is the use of enzymatic transformations. [20, 21] The regiospecificity of enzymeso ffers the possibility to avoid protection steps of the hydroxyl groups not employed in the transformation. This approachw as followed by severalr esearch groups: attention was focused on the identification of enzymesa ble to play ar ole in this synthesis. In an enzymaticp rocess for the production of UDCA from its precursors, severals teps have to be performed. These are hydrolysis/deconjugation of glycine and taurine CA derivatives (used as raw startingm aterial), the stereoinversion of the hydroxyl functions (by oxidation and subsequentr eduction)a nd the specific hydroxylation and deEpimerization of cholic and chenodeoxycholic acid (CA and CDCA, respectively) is an otable conversionf or the production of ursodeoxycholic acid (UDCA). Twoe nantiocomplementary hydroxysteroid dehydrogenases (7a-a nd 7b-HSDHs) can carry out this transformation fully selectively by specific oxidation of the 7a-OH group of the substrate ands ubsequentr eduction of the keto intermediate to the final product (7b-OH). With a view to developing robusta nd active biocatalysts,n ovel NADH-active 7b-HSDH species are necessary to enableasolely NAD + -dependentr edox-neutral cascade for UDCA production. Aw ild-type NADH-dependent 7b-HSDH from Lactobacillus spicheri (Ls7b-HSDH)w as identified, recombinantly expressed, purified, and biochemically characterized. Using this novel NAD + -dependent 7b-HSDH enzyme in combination with 7a-HSDH from Stenotrophomonas maltophilia permitted the biotransformations of CA and CDCA in the presence of catalytic amounts of NAD + ,r esulting in high yields (> 90 %) of UCA and UDCA.
hydroxylation of desirable positions in the steroid rings. [20] The epimerization reaction (stereoinversion of 7a-OH group)c an be performed by two enzymes (7a-a nd 7b-hydroxysteroid dehydrogenase (HSDH)): the first enzyme specifically oxidizes the 7a-OH group to the ketone,w hich is furtherr educed by the second enzyme to the corresponding alcohol group with inverted stereochemistry (7b-OH). HSDHs are enzymes of the class of alcohol dehydrogenases( ADH) that use NAD(P)
+ and NAD(P)H ast he electron acceptor and donor,r espectively.I n the literature, several cascades that use these enzymes are reported; [22] [23] [24] [25] [26] [27] however,s ince known enzymes have different cofactor specificities, that is, 7a-HSDHs are usually NAD + -dependent and 7b-HSDHsN ADPH-dependent, the oxidative andr eductive reaction steps are decoupled in currently reported procedures( Figure 1-state of art) . The cofactors, in this case, are regenerated by the addition of two other enzymesa nd two sacrificials ubstrates. [21] [22] [23] In this specific case, the reaction is driven towards completion by the addition of sacrificial substrate (in great surplus): Although good yields werea chieved (> 80 %), large amounts of side products and waste were formed that have to be removed during the downstream processings teps, increasing the overall cost and the environmental burden of UDCA production.
Pedrini et al.,a lready in 2006, [28] reported the successfule pimerization of CDCA to UDCA by using ac atalytic NAD + -dependentc ascade reaction, with two NAD + -dependent dehydrogenases isolatedf rom Xanthomonas maltophilia CBS 897.97 (recentlyr eclassified as Stenotrophomonas maltophilia). In this way the requirement of externalsystems for cofactor regeneration was circumvented and UDCA was obtainedw ith af inal yield of 75 %. However,t he cultivation of this class 2s afetylevel microorganism is complex [29] (microaerophilic conditions have to be used) and the 7a-HSDH and 7b-HSDH enzymes were only produced in low amounts( 4a nd 0.2 mg L culture À1 ,r espectively). In addition, the amino acido rD NA sequences of these enzymes were not reported, making the recombinant expression of these proteins not possible. Since the activity and cofactor specificity is not clear from sequence alone, the univocal identification of the target corresponding gene in genomes databases is not possible. Furthermore, other works [23, 24, 30, 31] have been reported on the employment of aN ADP + -dependent redox neutral cascade for CDCA epimerization;h owever, in comparison to NAD + ,t he use of NADP + is nonoptimalb ecause of the higherp rice, lower stability, [32] and lower natural availability.G enerally,b yt he employment of ar edox-neutral cascade, 80 %o fU DCA is produced.
In this paper,w er eport the development of an efficient enzymaticc ascade,u sing well defined and easy to produce enzymes, for the production of UDCA and ursocholic acid (UCA) from CDCA and CA, respectively.Af ull NAD + -mediated cascade, that circumvents the need for cofactor regenerationw as setup resulting in conversion above 90 %. The key discovery in this paper is the protein engineering of the NADP + -dependent 7b-HSDH from Clostridium sardiniense that led to the identification of key residues responsible for NAD/NADP cofactor recognition. With this new sequence at hand, the naturalN AD + -dependente nzymef rom Lactobacillus spicheri, was disclosed for the first time as being highly active in the reduction of the 7-oxo-derivatives of CA or CDCA to either UCA or UDCA.
Results and Discussion

Protein expression and purification
The genes coding for the Sm7a-HSDH, Cs7b-HSDH, and Ls7b-HSDH were clonedi nto pET24d(+ +)p lasmid,y ieldinge nzymes Figure 1 . Epimerization of the 7a-OH groupo fC Aand CDCA. In our work, the NADH produced in the first reaction step (oxidation of 7a-OH) is reused by a NADH-dependent 7b-HSDH giving the 7b-OH epimer. E1 and E2 are two additional enzymes(i.e.,alcohol dehydrogenases) used to regenerate the cofactors converting the sacrificial substrates 1 and 2,respectively,i nto waste products. containing aC -terminal 6 His-tag. The recombinant enzymes were produced in E. coli BL21(DE3) host cells grown at 37 8Ci n LB medium. Isopropyl b-D-1-thiogalactopyranoside (IPTG) was added at the late exponential phase of growth and the cells were collected after another 18 ho fi ncubation at 25 8Cw hile shaking. The expression level under these conditions of the different proteins is reported in Table 1a nd Ta ble S2, Supporting Information. The His-tagged enzymes werep urified by HiTrap chelating chromatography;a ll of the enzymes were isolated with ! 95 %p urity,a sj udged by SDS-PAGE analysis ( Figure S2 , Supporting Information).
Mutagenesis of Cs7b-HSDH
Since the 3D structure of 7b-HSDH from C. sardiniense is unknown,amodel of the protein was built by using the comparative homology-modeling server SWISS-MODEL. [33] 7b-HSDH from Collinsella aerofaciens (PDB code 5GT9) was chosen as a template because of the high sequence identity (42 %) with Cs7b-HSDH. [34] The binding mode of the co-substrate NADP + in the model of the Cs7b-HSDH active site wasa nalyzed;t he ribose-bound phosphate group interacts with two arginine residues (R40 and R41) (Figure 2a ). On the basis of the in silico analysis, site-saturation mutagenesis( SSM) [35] was performed at positions 39, 40, and 41 by using the QuikChange kit and the wild-type Cs7b-HSDH cDNA as at emplate. In the first round of mutagenesis, an aspartate was specifically introduced at position39, whereas positions 40 and 41 were more randomly changed. The use of aD HK [36] The use of this codon drastically reduces the number of clones that have to be screened. The activity of Cs7b-HSDH variants on NAD + as ac o-substrate was screenedi namicrotiterp late by using as pectrophotometric method( production of NADH, measured at 340 nm) and an automated liquid-handling system. For the first round of mutagenesis, (G39D,R 40X, and R41X), 769 clones were screened, giving ap robability of 91 %t hat every combination of amino acids is measured. The clones most active on NAD + as identified through the screening procedure were isolated and the substitutions were identified by DNA sequencing.
After the first round of mutagenesis and screening mosto f the enzymev ariants obtainedw ere inactive or had an activity lower than the control activity of wild-type Cs7b-HSDH on NAD + (ca. 1mUmL À1 under these conditions). However,f our Cs7b-HSDH variants were isolated that showed ac lear activity on NAD + :G 39D, R40L, R41N (DLN variant);G 39D,R 40F,R 41F (DFF variant);G 39D, R40K, R41S (DKS variant);a nd G39D, R40K, R41V (DKV) variant. From the molecular modeling of these variants it could be observed that the hydroxyl group of threonine at position17c ould interfere with aspartate 39 in the hydrogen bonding of the free OH-group of ribose (Figure 2b) . A second pair of degenerated primers were designed to mutate that threonine (T17X). For this second round of mutagenesis, all four variants were used as template for the mutagenesis and 380 clones (96 clones for each variant)w ere screened (99 %c overage). Out of all screened mutants, one variant (T17A, G39D, R40L, R41N-ADLN variant) showedavery high activity towards NAD + as ac osubstrate in the microtiterp late assay employing cell extract ( Figure 2c ).
The ADLN variant was expressed in E. coli BL21(DE3) cells and purified by HiTrap chelating chromatography (> 90 % purity). This variant shows an expression yield similart ot hat of the wild-type Cs7b-HSDH (in terms of purified protein/litero f fermentation broth, see Ta ble S2, Supporting Information). The Michaelis-Menten kineticso fa ll selectede nzyme variants were measured using NAD + or NADP + as acofactor. As shown in Table 2 , among the Cs7b-HSDH variants obtained by SSM, the ADLN was identified because of at hirtyfold increasei ns pecific activity compared to the wild-type enzyme.
To further increase the activity on NAD + ,t he T17A, E18D, G39D, R40L, R41N (ADDLN) variant was designed andr ecombinantly expressed;t he substitution of the glutamate with the smaller aspartate at position18m ay result in the formation of as econd hydrogen bond between the cofactor and the protein (Figure 2d ). The comparison of the kineticp arameters of the ADLN and ADDLN variants of Cs7b-HSDH indicates that the addition of as econd hydrogen bond increases the affinity of the ADDLN variant for the NAD + (eight-fold decrease in K m ), see Table 2 . However,t he specific activity on NAD + of this variant decreases (10-fold lower in comparison to the previous isolated one). To restoret he specific activity on NAD + af ourth round of SSM was carriedo ut employing the same primers Table 2 . Kinetic parameters of purified recombinant 7b-HSDHs on NADP + and NAD + .The kinetic parameters were determined in the presence of 1.0 mm UDCA. The preference is calculated as the ratio between the catalytic efficiency on the two cofactors.
wt Cs7b-HSDH (Table 2) . Interestingly the affinity for the cofactor is lower than the one observed in the previousv ariants. However,t he expression level of this protein is 15-foldh igher than the wild-type Cs7b-HSDH (486 vs. 20 mg L culture
À1
), resulting in the higher activity under the screening conditions. Overall, we conclude that ADLN is the best-obtained variant for our purpose due to its highestc atalytic efficiency.
7b-HSDH from Lactobacilluss picheri
With the new sequence of NADH-dependent7 b-HSDH (ADLN and ADDLN variants) in hand, an ew alignment search was carried out to find potentially better,p reviously nonidentified enzymes, able to convert CA and its derivatives. The Ls7b-HSDH sequence was identified using the Basic Local Alignment Search Tool (BLASTp);t he predicted sequence analysis showed a7 92 bp ORF correspondingt oap rotein of 264 amino acid residues.
This enzymew as identified as ap utative NADH-dependent 7b-HSDH based on the fact that the amino acids relevant to the binding and recognition of NADH are present;s pecifically, the alanine and aspartate at positions1 8a nd 19 and the stretch DYS at positions 40-42 are conserved, [37] analogous to the situation in analogue Cs7b-HSDH (Figure 3b ). The predicted M w of 29 kDa and the predicted homodimeric quaternary structure( Figure 3a )p ut Ls7b-HSDH in the short chain dehydrogenase/reductase superfamily.
Biochemical characterization of HSDHs
Sm7a-HSDH showedas trict NAD
+ activity on both CDCA and CA, although the activity on CA is considerably lower (halved). No activity was detectedw hen NADP + was used as an electron acceptor. Sm7a-HSDH displayed a K m of 0.22 and 0.96 mm for CDCA and CA, respectively.T he Sm7a-HSDH did not show any substrate inhibition on CA, but a K i of 11 mm on CDCA was measured. The K m value for NAD + is 0.55 mm (Table 3) , which is similar to earlier reportede nzymes.
The pH and temperature dependence of Sm7a-HSDH activity was investigated;b oth the maximum activity and stability occurred at slightly alkaline pH values (Figure 4a ). The enzyme is quite thermophilic,s howing an optimum at around7 0 8C (Figure S3 a, Supporting Information), and is quite stable;a fter 24 hi ncubation at 25 and 37 8C, the enzyme maintained approximately 100 and 70 %o fi ts initial activity,r espectively.I ncubations at highert emperatures (60 8C) resulted in ac omplete loss of enzymatic activity.T he enzymatic activity of Sm7a-HSDH was also investigated in the presence of different concentrations of methanolt hat could be used as ap otential co-solvent in order to increaset he solubility of hydroxysteroids in water.T he enzymes hows no loss of activity in 10 %m ethanol and it conserves 90 %o fi ts activity in 20 %m ethanol (Figure 5a) .
On the other hand, wild-type Cs7b-HSDH showedastrict NADP + activity on UDCA (0.74 Umg À1 under standard conditions). The activity on NAD + is roughly1 00-fold lower showing a K m of 2.6 mm and as pecific activityo f0 .023 Umg
À1
. Cs7b-HSDH displayed a K m of 0.16 mm for UDCA (Table 4 ). The pH and temperature dependence of Cs7b-HSDH activity was investigated:b oth the maximum activity and stability occurred at slightly alkaline pH values (Figure 4b) . Notably, the pH optimum for the reductionr eactions was detected at pH 6-7. In the presence of NADPH, this enzymei sa ble to reduce both 7-oxo-DCAand 7-oxo-LCA (LCA:l ithocholic acid;see Ta ble 4).
In general, the enzyme is lesst hermophilic than the Sm7a-HSDH, showing an optimum at around6 08C ( Figure S3 b, Sup- Figure 3 . 3D model of Ls7b-HSDH built employing the entire structure of 7b-HSDH from Collinsella aerofaciens (PDB code 5GT9) as atemplate:the homodimeric quaternary structure (a) is conserved. The hypothetical binding mode of NADH (b) is primary due to the side chains of D19 and D40 to the 3' and 2'-OH groups of ribose, respectively. Table 3 . Kinetic parameters of purifiedr ecombinant Sm7a-HSDH.
CA [a] 497. porting Information), and less stable:a fter 24 hi ncubation at 25 and 37 8C, Cs7b-HSDH maintained approximately 85 and 62 %o fi ts initial activity,r espectively. Cs7b-HSDH shows a good tolerance to concentrations of methanol above 10 %, and 70 %o fi ts activity is conservedi nt he presence of 20 % methanol.
The ADLN, ADDLN, and ADDAA variants showed an increase in activity towards NAD + and NADH as ac osubstrate, with little change in specificity for the different substrates (Table 4) .
Interestingly,t he isolated variants showed higher stability than the wild-type Cs7b-HSDH. From this comparison, it can be observed that the ADLN variant maintains 95 %o fi ts activity after incubation for 24 ha t2 58C( compared to the 85 %f or the wild-type under the same conditions).
As predicted by in silico analysis, Ls7b-HSDH showedastrict NAD + activity( 3.10 Umg À1 in standard condition). Aw eak activity was detected when NADP + was used as an electron acceptor (Table 2 ). Ls7b-HSDH showed a0 .15, 0.04, and 0.13 mm K m for UDCA, 7-oxo-LCA, and 7-oxo-DCA, respectively. Ls7b-HSDH is inhibited by UDCA showingaK i of 0.8 mm for this substrate. The K m value for NAD + is 0.08 mm.F rom all the 7b-HSDH-variants in this paper,t his enzyme shows the highest NAD + /NADH activities for both the reductiona nd the oxidation of 7b-OH hydroxysteroids and its derivatives. All kinetic data are presented in Ta bles 2and 4.
From the biochemical characterization it can be observed that this enzyme showeds imilar features to the other isolated enzymes,w ith the exception of the pH dependence;t he maximum activity for both oxidation and reduction reactions was observed at lower pH (6-7) (Figure 4f ).
Ls7b-HSDH is quite thermophilic,s howing an optimum at around7 0 8C ( Figure S3 C, Supporting Information), and it is stable at 25 and 37 8C, maintaining, after 24 ho fi ncubation, approximately 98 and 72 %o fi ts initial activity,r espectively. Ls7b-HSDH conserves 60 %o fi ts activity in the presence of 20 %m ethanol; thus, for follow-up bioconversion studies 10 % methanolw as used, which limits the amount of substrate that can be loaded in ab iotransformation (Figure 5f ). Bioconversion of CDCA and CA To assay the applicability of the enzymes described above as a biocatalyst fort he productiono fU DCA and UCA in ab atch bioreactor, lab-scale bioconversions were carried out:1 0mmol of CDCA in the presence of 1 mmol of NAD + and 10 %M eOH was converted into UDCA (92 %y ield) in 200 min by 1U of Sm7a-HSDH (0.23 mg) and 0.6 Uo fLs7b-HSDH (190 mg) (Figure 6a) . HPLC analysiss howedn of ormation of undesired products,e xcept for the 7-oxo-LCA (0.5 mmol), intermediate of the enzymatic cascade (Figure S4 a, Supporting Information) . Under the same conditions, 10 mmol of CA was convertedi nto UCA (91 %) in 120 min (Figure 6b) . Surprisingly,t he addition of MeOH (10-20 %) resulted in an increase( 10 %) of conversion (Table 5) : without cosolvent only 80 %o fU DCA can be obtainedb yt his biotransformation. The effect of cosolvents on the equilibrium of the epimerizationr eaction wasa lready discussed in the literature [38] but never observed for this specific biotransformation.
Additionally,t oo ptimize the reactionc onditions, as et of bioconversions were carriedo ut:a sr eported in Table 5 , > 90 % of UDCA was observed when employing 1o r0 .5 mmol of NAD + .B iocatalytic conversions were also carriedo ut in the presence of 0.2 mmol of NAD + by using CDCA as as ubstrate; in this case, the conversion is slower,y ielding2 4% of UDCA in 20 h ( Figure 6c) . Notably,h ere the detected amount of keto intermediate was lower than 1% (0.1 mmol). Bioconversions were also tested at different pH values (6 and 7) but no improvementsw ereo bserved (after 150 min in the presenceo f1m m NAD + ,7 7, 81, and 87 %c onversion was observeda tp H6,7 , and 8, respectively). Unfortunately,t he increaseo fs ubstrate loading to 20 mm negatively affects the bioconversion, yielding 20 %o fp roduct after 12 hofi ncubation.
The ADLN variant of Cs7b-HSDH was also tested in the cascade reaction in the presence of 1mm NAD + for the epimerization of CDCA and CA;a lthough, no conversion was observed when CDCA was used as as ubstrate, 10 mmol of CA wasc onverted into UCA (91 %y ield) by 790 mgo fe nzyme after 30 min (Figure 6d and Figure S4 b, Supporting Information). This behavior can partially be explained by the kinetic parameters of this variant: K i for the intermediate 7-oxo-LCA is four times lower than the one for 7-oxo-DCA.
Notably,i nt he different bioconversions the amount of keto intermediate is limitedb yt he amounto fc ofactor used. Thus in at ypical reaction in which 10 %c ofactor was used, 5% keto intermediate was formed as ab yproduct.
Conclusions
Epimerization of CA andi ts derivatives is ap ivotals tep in the synthesis of UDCA (see Figure 1) . Enzymatic epimerization circumvents the need for protection/deprotection steps and can be carried out with ahigh yield. Asolely NAD + -dependentcascade for CDCA and CA epimerization,i nw hich NAD + is present in catalytic amounts, represents ap romising method for a more efficient process in terms of atom economy and number of reagents required. To achievet his goal it is fundamental to Table 4 . Kinetic parameters of purified recombinant 7b-HSDHs on different substrates. employ robust, active, and selective enzymes: Sm7a-HSDH shows kinetic parameters better or comparable to its E. coli or Bacteroides homologues, widelyu sed by researchers in these kinds of processes. [22, 27, 39] This enzyme selectively oxidizes the 7a-OH group of CA and CDCA. In terms of stabilityi ts hows promising tolerance to the presence of methanol and elevated temperatures.
Until now,a ll sequences of 7b-HSDHsr eported in the literature are NADP + -dependent enzymes. [20] However,p rotein engineering provides as traightforward method to change cofactor specificity;t his has been the subjecto fm any pieces of research in both academia and industry over the past few decades. [40] [41] [42] Unfortunately,t he resulting enzymes usually have a perfect cofactor switch, but in several cases the enzyme activity and/ors ubstrate specificity decreasest remendously. [43] A softwarea pparatus fort he prediction of the specificity-determining residues (CSR-SALAD [44, 45] )h as been developed and is now widely used, [46] but there is still no comprehensive solution for cofactor switching.
Following this approach, an iterative mutagenesis of Cs7b-HSDH was performed.Asemirational approach was pursued, based on the identification of the residues responsible for the cofactor recognition discovered in the homology model of the enzyme.
In this way,r esidues G39, R40, and R41 were identified to be responsible for binding of the phosphate group at the 2'-position of ribose. Interestingly,t he importance of arginine in the binding of NAD(P)
+ has been shown previously on the enantiocomplementary 7a-HSDHs [47] .T he amino acid at position 39 was mutated to an aspartate. Notably,asimilara ttempto fc ofactor switching, performedb yB akonyi and Hummel on the Clostridium difficile 7a-HSDH, [48] has led to the identification of similarv ariants (A37D). In our case, the free hydroxyl group at 2'-of ribose forms ah ydrogen bond with the aspartate (length 2.2 ). R40 and R41 residues were randomly mutagenized in order to identify ac ouple of amino acids that 1) do not interfere with aspartate in NAD + binding and 2) create ab inding pocket for NAD + .S SM with limited codons helped to introduce ac ertaind egree of variabilityi nt he protein while generating smartl ibraries containing < 1000 clones for each round.
In the same way,T 17 was subjected to SSM. From the 3D structure of the model it was observed that the OH group of the side chain is 2.5 from the aspartate. The obtained ADLN variant showsareasonable activity on NAD + (in comparison with the wild-type enzyme on NADP + ). The K m of this variant for NAD + is 2mm,whichisactually close to the value reported by Pedrini et al.,f or their 7b-HSDH from S. maltophilia. [28] Additionally,t he mutationE 18D improved the affinity for NAD + about 10-fold;h owever,u nfortunately,t he specific activity of the protein decreases.W eh ypothesize that the E18 residue in the Cs7b-HSDH also has as tructural role. From this optimization round we thus concluded that the ADLN variant was the best mutant.
These data suggest that the efficiency and the selectivity in cofactorb inding depends, for al arge part, on the molecular dynamics of the Cs7b-HSDH.A lthough this feature canb er easonably simulated, the engineering of the target enzyme is still complex. [49] For this reason,a ttention was focusedo nt he identification of aw ild-type enzymet hat conserved both 1) the structure of Cs7b-HSDH and2 )the residues identified in Cs7b-HSDH to be responsible forc ofactor recognition.T he new analysisl ed us to identify as equence of ap utative NAD + -de- + -dependent activity (K m 80 mm)a nd an activity higher than the Cs7b-HSDH on the respective cofactor. As shown, both the ADLN variant of Cs7b-HSDH and the Ls7b-HSDH are suitable for the epimerization of CA (to UCA);h owever,o nly the Ls7b-HSDH is ablet oe pimerize CDCA (to UDCA). This can partially be explained by the comparison of the kinetic parameters of the two enzymes;f irstly,t he ADLN variant,a lthoughi tw as engineered, shows a K m for the NADH3 5-fold higher than the Lactobacillus one. Secondly, the ADLN variant is inhibited by 7-oxo-LCA (K i = 2.0 mm). In general, Ls7b-HSDH is am ore interesting biocatalyst because of the high activity on both 7-oxo derivatives.
Bioconversions were carried out at the substrate concentration used in previous studies (10 mm). This choice was taken in order to 1) have as traight comparison between the reported systemsa nd the current redox neutralc ascadea nd 2) ensure solubility,b ecause solubility of CDCA in aw ater environment (pH 8.0) is low (around 10 mm as specified by Zheng [23] ). The developed cascade showsa ne pimerization yield > 90 % for both CA and CDCA under nonoptimized conditions. This shows that the currentlyd eveloped set of enzymes and the epimerization cascade belonging to it provides ah ighly promising alternative for both chemical and enzymatic synthetic procedures applied currently. [20, 21] This could provide ab asis for am uch more elegant and atom-efficient synthesis of UDCA from CDCA.
Since the epimerization of CA and CDCA is carriedo ut with catalytic amountso fN AD + ,t he shift of the equilibrium depends on the difference in physiochemical properties between reagents and products.P articularly,i napreliminarys tudy using am olecular mechanics approach, we have identified a difference in the DG 0 between the two epimers of À1.23 kJ mol À1 (calculated at standard conditions). In addition, the differencesi ns olubility and in criticalm icelle concentration (CMC) of the two isomers can play ar ole in the shift of the equilibrium to the products. Similar results were shown by the Dangate et al. [18] and Giovannini et al. [50] in chemical and chemoenzymatic routes, respectively.D angate et al. reported that 7-oxo-DCA is preferably reduced to the 7b epimer (UCA/CA = 80:10 %y ield) in the presence of sodium in anhydrous n-propanol. Under the same conditions, Giovanninie tal. showed similar results for the reduction of 7-oxo-LCA (UDCA/CDCA 82:15 %y ield). In addition, in our case we observed that the reduction towards the 7b epimer is thermodynamically favored;h owever,i nc ontrast to the chemical cascade, the reversibility of the enzymatic catalyzed reactions allows the thermodynamic equilibrium betweent he two epimers to be reached. In comparison to the previously reportedN ADP + -dependent redox neutrals ystems we observed ah igher conversion yield (> 90 vs. 80 %. reported by Zhenge tal. [23] ). This increasec an be explained by the use of the cosolvent( 10 %M eOH) that influences the reaction environment( Ta ble 5) withouta ffecting the activityo ft he employed enzymes. Another advantage of our system is given by the use of NAD + instead of NADP + ,w hich lowerst he cost of the required cofactor and showsh igher stability in solution.
As previously observed by Zheng et al., [23] in all the epimerization reactions, 5% of keto intermediate (7-oxo-DCA or 7-oxo-LCA) was obtained:f or future studies, since the amount of intermediate is relatedt ot he amount of cofactor in solution, lower NAD + concentrationss hould be used to decrease this byproduct at the expense of al onger reaction time (e.g.,i f 0.2 mm NAD + is used, the amount of intermediate cannot exceedt he 2%). To evaluate the performance of our system, process metrics werec alculated:u nder the conditions described in this study (1 and 0.6 UmL À1 of Sm7a-HSDH and Ls7b-HSDH,r espectively), the system shows aT TN of 2.9 million and as pace-time yield of 26 gL À1 d
À1
.D espite ag ood TTN, the space-time yield is not yet high enough for industrial application. Further studies, including the use of flow reactors, will be carriedo ut to address the downstream processing aspects of this reaction. This, in combination with solvente ngineering and the employmento fb iphasic systems, both targeted to the increaseo fsubstrate loading (and decrease the cofactor loading), could optimize the conditions for the industrial preparation of UDCA. [51] In conclusion, we have shownt hat the epimerization reaction of CA and CDCA can be achieved by at woenzyme-one-cofactor cascade that benefits from favorable thermodynamics for the 7b-OH isomer.I np articular, Sm7a-HSDH and Ls7b-HSDH are ac ompatible, stable set of enzymes and promising candidates as biocatalysts in the synthesis of hydroxysteroid derivatives. Further investigationsw ill be carried out to develop af low system or am embrane reactor similar to the ones described in literature [22, 52] for our newly developed biocatalytic UDCA synthesis procedure and to increase the substrate loading in the process.
Experimental Section
Bacterialstrainsand materials 
) were purchased from Invitrogen (Darmstadt, Germany). Tryptone, yeast extract, cholic acid, ursodeoxycholic acid, and nicotinamide adenine dinucleotide cofactors (NAD(P)
+ /H) were from Sigma-Aldrich (St. Louis, US). Ursodeoxycholic acid was from To kio Chemical Industry (TCI) (Tokyo, Japan). Restriction enzymes and Phusion Q-5 DNA polymerase mastermix were from New England Biolabs (NEB, Ipswich, US). All other reagents were of analytical grade and are commercially available.
Identifying and homology models of 7a-hydroxysteroid dehydrogenases
The 7a-hydroxysteroid dehydrogenase from Stenotrophomonas maltophilia (Sm7a-HSDH) and 7b-hydroxysteroid dehydrogenase from Lactobacillus spicheri (Ls7b-HSDH) gene sequences were identified by multiple sequence analysis using BLASTp (NCBI, https:// blast.ncbi.nlm.nih.gov): for Sm7a-HSDH, protein sequences with known activity from Clostridium sardiniense (GenBank:A ET80685. Figure S1 b. The 3D models of Cs7b-HSDH (GenBank:A ET80684.1) and Ls7b-HSDH were built using the same server employing the entire structure of 7b-HSDH from Collinsella aerofaciens (PDB code 5GT9) as template.
Cloning and expression of Sm7a-HSDH, Cs7b-HSDH, and
Ls7b-HSDH
The synthetic cDNAs encoding the Sm7a-HSDH, Cs7b-HSDH, and Ls7b-HSDH were designed by in silico back translation of the amino acid sequences (GenBank:K RG42928.1, AET80684.1, and WP045806907, respectively). To subclone into the pET24d(+ +)p lasmid (Merck Millipore, Burlington, US), sequences corresponding to NcoI( CCATGG) and XhoI( CTCGAG) restriction sites were added at the 5'-a nd 3'-ends of the cDNAs, respectively.T he codon usage of the synthetic genes was optimized for expression in E. coli and produced by BaseClear B.V.( Leiden, The Netherlands). Sm7a-HSDH, Cs7b-HSDH, and Ls7b-HSDH cDNAs were cloned into the pET24d(+ +)v ector using the NcoIa nd XhoIs ites, resulting in a6 .0-, 6.0-, and 6.1-kb construct (pET24-Sm7a-HSDH, pET24-Cs7b-HSDH and pET24-Ls7b-HSDH). The genes were cloned in frame with the C-terminal 6-Histidines tag of the vector.T he obtained expression plasmids were then used to transform BL21(DE3) E. coli cells.
Starting cultures (100 mL) were prepared from as ingle recombinant BL21(DE3) E. coli colony grown in LB medium containing kanamycin (30 mgmL À1 ), under vigorous shaking (200 rpm) at 37 8C. These cultures were diluted to as tarting OD 600nm of 0.1 in 1Lof LB medium (LB, 10 gL À1 bactotryptone, 10 gL À1 NaCl and5gL À1 yeast extract) and then incubatedat378Conarotatoryshakerat200 rpm untila nO D 600nm of 1.0w as reached.P rotein expression wasi nduced by adding 0.25 mm IPTG:c ulturesw ereg rown fora nother 12 ha t 25 8Cw ithshaking (200 rpm).C ells were harvestedb yc entrifugation at 10 000 g for1 0min at 4 8C, washed with 50 mm KPib ufferp H8.0 and stored at À20 8Cf or at least 1day before purification.
Protein purification E. coli cell pellets were resuspended in lysis buffer (50 mm KPi buffer,1m NaCl, 5% glycerol (v/v)a nd 10 mgmL À1 DNAse, pH 8.0) and disrupted by French press (Constant Systems Limited, Low March, UK) (2 cycles, 180 psi). The insoluble fraction of the lysates was removed by centrifugation at 39 000 g for 30 min at 4 8C. Crude extract was loaded onto aH iTrap chelating affinityc olumn (GE Healthcare, Little Chalfont, UK), previously loaded with Ni 2 + metal ions and equilibrated with 50 mm KPi buffer,1m NaCl and 5% glycerol (v/v), pH 8.0. The columns were washed with this buffer untilt he absorbance valuea t2 80 nm wast hat of theb uffer andthe boundproteinsweree lutedwith50mm KPibuffer, 250mm imidazole, and5 %g lycerol( v/v), pH 8.0. Thef ractions containing thed esired activity were dialyzed overnighta gainst 50 mm KPi buffer and5 %g lycerol( v/v), pH 8.0, usinga3-kDad ialysist ube. During thep urificationp rocedure,7 a-HSDHa nd 7b-HSDHa ctivities were assayed by using the standard activity assay (see below).
Activityand kinetic measurements
7a-HSDH'se nzymatic activity in the crude extract and of the purified enzyme was determined at 25 8Cu sing 1.0 mm CDCA, 2.0 mm NAD + ,i n5 0mm KPi buffer and 10 %m ethanol (v/v), pH 8.0. 7b-HSDH'se nzymatic activity was determined at room temperature (25 8C) using 1.0 mm UDCA, 2.0 mm NAD(P) + ,i n5 0mm KPi buffer and 10 %m ethanol (v/v), pH 8.0. The production or the consumption of NAD(P)H was followed at 340 nm (extinction coefficient of NAD(P)H is 6220 Lmol À1 cm
À1
). One unit (U) was defined as the amount of enzyme producing 1 mmol of product per minute at 25 8Ca nd at pH 8.0. Blank measurements were performed in absence of CDCA or UDCA, NAD + ,a nd enzyme.
The kinetic parameters of the purified samples were determined at room temperature in the presence of different concentrations of substrates (5-10 000 mm), 2.0 mm NAD(P) + in 50 mm KPi buffer and 10 %m ethanol (v/v), pH 8.0, at 25 8C; different concentrations of NAD(P) + (1-5000 mm), 2.0 mm CDCA (for 7a-HSDH) or UDCA (for 7b-HSDH) in 50 mm KPi buffer and 10 %m ethanol (v/v), pH 8.0, at 25 8C. The specific activity was expressed as unit per mg of protein (determined by spectrophotometric analysis at 280 nm). The kinetic data were fitted to the Michaelis-Menten equation, or to the one modified to account for substrate inhibition when necessary.
The effect of pH on the enzymatic activities was determined by using 1.0 mm CDCA (for 7a-HSDH) or UDCA (for 7b-HSDH), 2.0 mm NAD(P) + ,i n1 00 mm citrate-phosphate buffer (66 mm citrate, 34 mm Na 2 HPO 4 )a nd 10 %m ethanol (v/v), in the 3.0-10.0 pH range.
The effect of methanol concentration on the enzymes activity toward CDCA and UDCA was determined using 1.0 mm CDCA (for Enzymatic stability was measured by incubating the enzyme solution in 100 mm citrate-phosphate buffer (66 mm citrate, 34 mm Na 2 HPO 4 )i nt he 3.0-9.0 pH range at 25 8C, [53] in 50 mm KPi buffer with different concentrations of methanol (0-50 %( v/v)) at pH 8.0 at 25 8Ca nd in 50 mm KPi buffer,a tp H8.0 at different temperatures:s amples were withdrawn at different times and residual activity was determined using the enzymatic activity assay.
SDS-PAGE
Proteins from crudee xtract and thep urifiede nzymef ractions were separated by SDS-PAGE on a1 2% polyacrylamider esolving gel (BioRAD, Hercules,U S).S amples werer e-suspendedi na na ppropriate volumeo fL aemmli sample buffera nd boiled. Proteinsw erev isualized by staining with SimplyBlue safe stain (Novex,C arlsbed, US).
Site-saturation mutagenesis(SSM) and screeningN AD + + -dependent enzyme variants SSM was carried out at different amino acid positions of Cs7b-HSDH by using whole plasmid PCR; [54] pET24d-Cs7b-HSDH vector as at emplate and as et of degenerated synthetic oligonucleotides was employed to prepare the mutant libraries (Table S1 , Supporting Information). PCRs were carried out in af inal volume of 20 mL. In all cases, 1 mLo ft emplate DNA (ca. 25 ng mL À1 ), 0.5 mLo fe ach primer (final concentration 0.25 mm), 10 mLo fP husion Q-5 DNA polymerase mastermix and 8 mLo fMilliQ water were added in sterile PCR tubes. After an initial denaturation step (98 8Cf or 1min), the reaction was carried out for 30 cycles (denaturation at 98 8Cf or 30 s, annealing at 58 8Cf or 30 sa nd elongation at 72 8Cf or 7min). Af inal elongation step (72 8Cf or 7min.) was added. The template DNA was eliminated by enzymatic digestion with 1 mL DpnIr estriction enzyme at 37 8Cf or 2h;t he PCR products were used to transform E. coli TOP10 cells. Subsequently,t he recombinant plasmids were transferred to E. coli BL21(DE3) cells, and these clones were used for the screening procedure. The introduction of the mutations was confirmed by automated DNA sequencing. The mutant libraries obtained from SSM were screened by means of ar apid colorimetric assay based on the reduction on NAD + (as described before) and by means of an automated JANUS Liquid Handler Workstations (Perking Elmer,W altham, US). To as aturated E. coli culture (1 mL, growth in 2mLD eepWell plate) 0.250 mm IPTG were added and the culture was then incubated at 25 8Cf or 18 h. The culture was centrifuged at 5000 g for 2min, and the cell pellet was resuspended in 50 mm KPib uffer, pH 8.0( 200 mL) containing 1mgmL À1 of lysozyme.C elllysis was performed incubating the plate for3 0min at 37 8C, 200rpm.T he crudee xtractsw erec entrifuged at 5000g for3 0min and then 50 mLo ft he supernatant was transferred to a9 6-well flat-bottom plate. The activity was assayed on the crude extractb ya dding 150 mLo f1 .33X substrate solution (1.33mm UDCA, 2.66 mm NAD + ,1 3.3 %M eOH in 50 mm KPi buffer,p H8.0).
The initial activity was determined by measuring the increase of the absorbance at 340 nm for 5min at 25 8Ci namicrotiter plate reader (Synergy2, Biotek, Winoosky,U S) and compared with cultures expressing the wild-type Cs7b-HSDH and untransformed cells as controls. The selected variants were sequenced and biochemically characterized.
Preparation of 7-oxo-DCA, 7-oxo-LCA,UCA, and UDCA
In a2Lr ound-bottomed flask CA (2.1 g), NAD + (133 mg), and oxalacetate (1.98 g) were dissolved in 50 mm KPi buffer,p H8.0 with 10 %M eOH (final volume:1 L). The reaction was initiated by adding Sm7a-HSDH (5100 U tot ;1 5mg) and malate dehydrogenase (200 U tot ;Sigma-Aldrich, St. Louis, US).
The reaction was gently stirred at 25 8C. Conversion was checked with HPLC. At completion of the reaction (ca. 1h)t he solution was acidified with HCl till pH 2.0 was reached, leading to the formation of aw hite suspension. To increase the precipitation, NaCl (50 g) was added and dissolved. The product was filtered with ap orous glass filter and washed with 0.01 m HCl solution (20 mL). The powder was then dried and crystallized in MeOH, giving 7-oxo-DCA. Yield:1 .9 g( 95 %);p urity:9 8% (assayed by HPLC analysis); 13 13 CNMR spectra are reported in Supporting Information.
The same procedure was used for the preparation of 7-oxo-LCA from CDCA (1.9 g). Yield:1 .6 g( 84 %);p urity:9 8% (assayed by HPLC analysis);
13 CNMR (100 MHz, DMSO): d = 211.40 (C 7 = O), 174.86 (COOH), 69.09 ppm (C 3 a-OH);f ull 1 Ha nd 13 CNMR spectra are reported in the Supporting Information.
UCA and UDCA were obtained by using the enzymatic cascade reported herein starting from CA and CDCA, respectively:C A( 0.55 g) or CDCA (0.51 g) and NAD + (86 mg) were dissolved in 50 mm KPi buffer,p H8.0 with 10 %MeOH (final volume:1 30 mL). The reaction was initiated by adding Sm7a-HSDH (63 U tot ;0 .18 mg) and Ls7b-HSDH (39 U tot ;1 2.54 mg). The reaction was gently stirred at 25 8C. After 24 h, the reaction was complete (92 and 91 %c onversion of CA into UCA and of CDCA into UDCA, respectively). The reaction was acidified with HCl (final pH 3.0) and extracted twice with 50 mL of diethyl ether.U DCA and UCA were purified by Reveleris X2 apparatus (GRACE, Columbia, US) equipped with C18 cartridge (40 mm, 12 g) employing water (TFA0 .1 %)/acetonitrile gradient. UCA:Y ield:4 78 mg (87 %);p urity: > 99 %( assayed by HPLC analysis); 13 Ha nd 13 CNMR spectra are reported in the Supporting Information. 1 Ha nd 13 CNMR spectra, in agreement with previous reports, [18, 29, 50] were acquired with Agilent ProPulse 400 MHz (Santa Clara, US) and are reported in the Supporting Information. Molecular mass of 7-oxo-DCA, 7-oxo-LCA, UCA, and UDCA were confirmed using an RP-ESI-Q-TOF-MS system (M-Class and Q-TOF Premier,W aters, UK), which was operated in positive ionization mode (ES +). Mass calibration was performed using [Glu 1]-Fibrinopeptide B. Data were analyzed using the MassLynx 4.1 tool box. The MS analyses are reported in the Supporting Information.
Bioconversion of CDCA to UDCA All bioconversions were carried out employing 1U tot of purified Sm7a-HSDS and 0.6 U tot of purified 7b-HSDS on 10 mm (if not differently specified) of CDCA or CA, NAD + (0.2, 0.5, or 1.0 mm). As a 
